Quote:
Originally Posted by OldBear
Thank you, Simon, that's good to hear.  One of my concerns with Phorm is that it won't be minor but instead that it's the thin edge of what will be an ever increasing wedge.
Just out of interest, have PI looked at Phorm in a similar manner to that which they looked at the Google/Doubleclick deal? |
PI looked at Google and Doubleclick because we've been following those organisations for years and know something about their infrastructure and core business. And, as JohnHorb pointed out, we published a broader overview of online advertising at
http://www.privacyinternational.org/article.shtml?cmd[347]=x-347-560974
We (as PI) held off on commenting about Phorm (beyond saying that it should be opt in) and will continue to hold off until we understand the complete operating environment. Once the PIA is in the public domain PI can join other organisations in expressing a full and frank opinion.
Simon